Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 12353311 | HLA (HLA) | peripheral stem cell transplantation | NA | NA | NA | unclassified | |
| after achieving the second cr, he received peripheral stem cell transplantation from his hla complete-matched sibling. | |||||||
| 15777349 | HLA IDENTICAL (HLA-IDENTICAL) | peripheral stem cell transplantation | NA | NA | NA | unclassified | |
| therefore, treatment was early intensified by myeloablative radio-chemotherapy and allogeneic peripheral stem cell transplantation from an unrelated hla-identical donor. | |||||||
| 26873735 | HLA IDENTICAL (HLA-IDENTICAL) | cyclophosphamide | Japanese | fludarabine | NA | unclassified | |
| NA | |||||||
| 30082853 | HLA MATCHED (HLA-MATCHED) | busulfan | NA | fludarabine | NA | unclassified | |
| NA | |||||||
| 17683828 | HLA-A*02 | chagas' disease | NA | NA | NA | unclassified | |
| the k1 peptide is an hla-a*0201-restricted cytotoxic epitope derived from the trypanosoma cruzi kmp-11 protein, this being the etiological agent of chagas' disease. | |||||||
| 16704757 | HLA-DRB1 (HLA-DRB1) | trypanosoma cruzi infection | Argentinian | NA | NA | unclassified | |
| hla class ii drb1 polymorphism in argentinians undergoing chronic trypanosoma cruzi infection. | |||||||
| 25688175 | HLA-G (HLA-G) | trypanosoma cruzi infection | NA | NA | NA | unclassified | |
| human leucocyte antigen-g (hla-g) and its murine functional homolog qa2 in the trypanosoma cruzi infection. | |||||||
| 25688175 | HLA-G (HLA-G) | chagas disease | NA | NA | NA | only_studied | |
| we evaluated the hla-g 3' untranslated region (3'utr) polymorphic sites (associated with mrna stability and target for microrna binding) and hla-g tissue expression (heart, colon, and esophagus) in patients presenting chagas disease, stratified according to the major clinical variants. | |||||||
| 25688175 | HLA-G (HLA-G) | chagas disease | NA | NA | NA | unclassified | |
| chagas disease patients exhibited differential hla-g 3'utr susceptibility allele/genotype/haplotype patterns, according to the major clinical variant (digestive/cardiac/mixed/indeterminate). | |||||||
| 20850383 | HLA-DRB1*08 | peanut allergy | NA | NA | NA | unclassified | |
| in conclusion, although drb1*0803 may identify a subset of families with increased risk of peanut allergy, differences in peanut-specific immunoglobulin production between peanut-allergic subjects and their peanut-tolerant siblings are independent of hla class ii. | |||||||
Copyright 2024